Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetylsalicylic acid for HIV prevention in female sex workers
NCT03629327Recruiting
- Sponsor
- University of Manitoba
- Start
- Jan 2022
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
Randomised, open-label trial of aspirin in human immunodeficiency virus infection (HIV) (3 arms), sponsored by University of Manitoba. Primary endpoint: Proportion of HIV Target cells (CD4+CCR5+) at 6 months. Started Jan 2022; status: recruiting.
02
Drugs
aspirin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03629327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03629327.